Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fagin, J. A.
Right arrow Articles by Brown, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fagin, J. A.
Right arrow Articles by Brown, A. T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 38, Issue 4 428-434, Copyright © 1989 by American Diabetes Association


ARTICLES

Coordinate decrease of tissue insulinlike growth factor I posttranscriptional alternative mRNA transcripts in diabetes mellitus

JA Fagin, CT Roberts, D LeRoith and AT Brown
Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine 90048.

In these studies, we examined the effect of excess levels of growth hormone (GH) on rat insulinlike growth factor I (IGF-I) gene expression in streptozocin-induced diabetes mellitus. A solution hybridization/RNase protection assay was used to simultaneously quantitate the relative tissue content of the variant IGF-I mRNA species arising from alternative splicing in the region encoding the COOH-terminal extension E-peptide (IGF-Ia and IGF-Ib). IGF-Ia and IGF-Ib mRNAs were markedly decreased in liver, kidney, and lung tissues of diabetic rats. Although GF stimulates IGF-I gene expression, chronic GH excess from implanted somatomammotropic tumors did not appropriately induce tissue IGF-I mRNA content in diabetic animals. Treatment of diabetic rats with insulin for 1 wk restored basal and GH-stimulated IGF-Ia and IGF-Ib mRNA content toward that present in tissues of nondiabetic rats. The ratio of IGF-Ia to IGF-Ib mRNA remained relatively constant for each tissue and was not affected by the diabetic state, chronic GH hyperstimulation, or insulin therapy, suggesting that posttranscriptional splicing is not a regulated event in these conditions. Thus, both circulating IGF-I levels and tissue IGF-I gene expression are profoundly decreased in this model of experimental diabetes. Diminished tissue availability of IGF-I from endocrine and/or paracrine sources may be responsible for the growth retardation seen in uncontrolled diabetes mellitus.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Nishiyama, D. N. Ishii, P. H. Backx, B. E. Pulford, B. R. Birks, and M. M. Tamkun
Altered K+ channel gene expression in diabetic rat ventricle: isoform switching between Kv4.2 and Kv1.4
Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1800 - H1807.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Gerhardinger, K. D. McClure, G. Romeo, F. Podestà, and M. Lorenzi
IGF-I mRNA and Signaling in the Diabetic Retina
Diabetes, January 1, 2001; 50(1): 175 - 183.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H.-X. Zhuang, L. Wuarin, Z.-J. Fei, and D. N. Ishii
Insulin-Like Growth Factor (IGF) Gene Expression Is Reduced in Neural Tissues and Liver from Rats with Non-Insulin-Dependent Diabetes Mellitus, and IGF Treatment Ameliorates Diabetic Neuropathy
J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 366 - 374.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Takeuchi, K. Takehara, K. Tajima, S. Kato, and T. Hirata
Impaired Healing of Gastric Lesions in Streptozotocin-Induced Diabetic Rats: Effect of Basic Fibroblast Growth Factor
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 200 - 207.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1989 by the American Diabetes Association.